A Randomized, Double-blind Study Evaluating the Upper Gastrointestinal Safety on Multiple Doses of CG100649 in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 11 Feb 2016
At a glance
- Drugs Polmacoxib (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- 27 Jan 2016 Study design has been changed from single group assignment to parallel group assignment according to ClinicalTrials.gov.
- 19 Nov 2015 Status changed from active, no longer recruiting to completed.
- 04 Oct 2010 Status changed from recruiting to active, no longer recruiting, based on a CrystalGenomics media release.